Approaches for genetic manipulation of Naegleria fowleri
Approaches for genetic manipulation of Naegleria fowleri
批准号:
10641130
负责人:
JAMES Culvin MORRIS
金额:
$19.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-01-09 至 2024-12-31
关键词:
AblationAddressAllelesAmoeba genusAreaAwarenessBasic ScienceBindingBiologyBrainCRISPR/Cas technologyCategoriesCell LineClassificationDetectionDevelopmentDrug TargetingGene ExpressionGene SilencingGene Transfer TechniquesGenerationsGenesGeneticGoalsInfectionInvadedLifeMediatingMolecularMutagenesisNaegleriaNaegleria fowleriNational Institute of Allergy and Infectious DiseaseNoseOrganismOutcomeParasitesPathogenicityPathway interactionsPharmacotherapyPhenotypeProcessProteinsRNA InterferenceReactionReagentResistanceTechnologyTherapeuticTherapeutic AgentsTransgenic OrganismsValidationWorkchemical geneticscontaminated waterdrug developmentdrug discoverydruggable targetfightinggene functiongenetic approachgenetic manipulationinhibitorinterestknockout geneloss of functionmortalitynovel strategiesnovel therapeuticsoverexpressionpathogenprimary amebic meningoencephalitispromotertargeted treatmenttherapeutic targettooltransgene expressionvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The goal of this proposal is to develop molecular tools and approaches for the study of the
pathogenic free-living amoeba Naegleria fowleri. These currently do not exist. This amoeba
is the causative agent of primary amebic meningoencephalitis (PAM), an almost invariable
lethal brain infection. The lack of useful drugs for the treatment of this infection emphasizes
the need to develop better therapeutic agents for amoebae infections. The lack of
understanding of gene function in the parasite remains a major hurdle in target-based drug
development campaigns. Here, we propose to address this problem by developing
approaches for gene silencing and ablation by RNAi and CRISP/Cas9-mediate gene editing
and transgene expression. These approaches will serve as an important first step in
understanding both gene function and essentiality, key to early-stage drug discovery efforts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enolase inhibitors as therapeutic leads for Naegleria fowleri infections
-
批准号:10739388
-
项目类别:
-
资助金额:$20.54万
-
财政年份:2023
-
负责人:JAMES Culvin MORRIS
-
依托单位:
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
-
批准号:10494462
-
项目类别:
-
资助金额:$220.95万
-
财政年份:2022
-
负责人:JAMES Culvin MORRIS
-
依托单位:
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
-
批准号:10666653
-
项目类别:
-
资助金额:$221.43万
-
财政年份:2022
-
负责人:JAMES Culvin MORRIS
-
依托单位:
Acquisition of the Agilent Cytation C10 confocal imaging reader for enhancing biomedical research excellence at Clemson University
-
批准号:10798537
-
项目类别:
-
资助金额:$29.61万
-
财政年份:2022
-
负责人:JAMES Culvin MORRIS
-
依托单位:
Nutrient sensing and hexokinases in T. brucei
-
批准号:7911534
-
项目类别:
-
资助金额:$1.14万
-
财政年份:2009
-
负责人:JAMES Culvin MORRIS
-
依托单位:
Nutrient Sensing and Hexokinases in T. brucei
-
批准号:8229951
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2008
-
负责人:JAMES Culvin MORRIS
-
依托单位:
Nutrient sensing and hexokinases in T. brucei
-
批准号:7454845
-
项目类别:
-
资助金额:$21.32万
-
财政年份:2008
-
负责人:JAMES Culvin MORRIS
-
依托单位:
Identification of Inhibitors of Trypanosoma Brucei Hexokinases
-
批准号:7459260
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2007
-
负责人:JAMES Culvin MORRIS
-
依托单位:
Glucose Sensing and Hexokinases in the African Trypanosome
-
批准号:9900822
-
项目类别:
-
资助金额:$22.11万
-
财政年份:--
-
负责人:JAMES Culvin MORRIS
-
依托单位:
Glucose Sensing and Hexokinases in the African Trypanosome
-
批准号:9261578
-
项目类别:
-
资助金额:$24.31万
-
财政年份:--
-
负责人:JAMES Culvin MORRIS
-
依托单位:
海外基金